474 related articles for article (PubMed ID: 30542738)
1. Tumor‑released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non‑small cell lung cancer.
Lei Y; Guo W; Chen B; Chen L; Gong J; Li W
Oncol Rep; 2018 Dec; 40(6):3438-3446. PubMed ID: 30542738
[TBL] [Abstract][Full Text] [Related]
2. Exosome-mediated transfer of lncRNA RP11‑838N2.4 promotes erlotinib resistance in non-small cell lung cancer.
Zhang W; Cai X; Yu J; Lu X; Qian Q; Qian W
Int J Oncol; 2018 Aug; 53(2):527-538. PubMed ID: 29845246
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA LINC00460 Promotes the Gefitinib Resistance of Nonsmall Cell Lung Cancer Through Epidermal Growth Factor Receptor by Sponging miR-769-5p.
Ma G; Zhu J; Liu F; Yang Y
DNA Cell Biol; 2019 Feb; 38(2):176-183. PubMed ID: 30601026
[TBL] [Abstract][Full Text] [Related]
4. Exosomal transfer of miR-214 mediates gefitinib resistance in non-small cell lung cancer.
Zhang Y; Li M; Hu C
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):457-464. PubMed ID: 30458987
[TBL] [Abstract][Full Text] [Related]
5. Exosome-mediated transfer of lncRNA‑SNHG14 promotes trastuzumab chemoresistance in breast cancer.
Dong H; Wang W; Chen R; Zhang Y; Zou K; Ye M; He X; Zhang F; Han J
Int J Oncol; 2018 Sep; 53(3):1013-1026. PubMed ID: 30015837
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA H19 confers resistance to gefitinib via miR-148b-3p/DDAH1 axis in lung adenocarcinoma.
Huang Z; Ma Y; Zhang P; Si J; Xiong Y; Yang Y
Anticancer Drugs; 2020 Jan; 31(1):44-54. PubMed ID: 31503013
[TBL] [Abstract][Full Text] [Related]
7. Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA.
Kang M; Ren M; Li Y; Fu Y; Deng M; Li C
J Exp Clin Cancer Res; 2018 Jul; 37(1):171. PubMed ID: 30049286
[TBL] [Abstract][Full Text] [Related]
8. E2F1-induced ferritin heavy chain 1 pseudogene 3 (FTH1P3) accelerates non-small cell lung cancer gefitinib resistance.
Zheng G; Chen W; Li W; Ding Y; Tu P; Chen W
Biochem Biophys Res Commun; 2020 Oct; 530(4):624-631. PubMed ID: 32762943
[TBL] [Abstract][Full Text] [Related]
9. TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway.
Xiao Z; Li M; Zhang X; Rong X; Xu H
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36896765
[TBL] [Abstract][Full Text] [Related]
10. Relationship between long non-coding RNA PCAT-1 expression and gefitinib resistance in non-small-cell lung cancer cells.
Wang S; Liu C; Lei Q; Wu Z; Miao X; Zhu D; Yang X; Li N; Tang M; Chen Y; Wang W
Respir Res; 2021 May; 22(1):146. PubMed ID: 33980216
[TBL] [Abstract][Full Text] [Related]
11. [FOXC1 Knockdown Reverses Gefitinib Resistance in Non-small Cell Lung Cancer].
Peng C; Li P; Yang M; Chen D; Huang Y
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):538-547. PubMed ID: 34334155
[TBL] [Abstract][Full Text] [Related]
12. Knockout of lncRNA UCA1 inhibits drug resistance to gefitinib via targeting STAT3 signaling in NSCLC.
Zhang B; Wang H; Wang Q; Xu J; Jiang P; Li W
Minerva Med; 2019 Jun; 110(3):273-275. PubMed ID: 30784252
[No Abstract] [Full Text] [Related]
13. Transcriptome analysis of EGFR tyrosine kinase inhibitors resistance associated long noncoding RNA in non-small cell lung cancer.
Ma P; Zhang M; Nie F; Huang Z; He J; Li W; Han L
Biomed Pharmacother; 2017 Mar; 87():20-26. PubMed ID: 28040594
[TBL] [Abstract][Full Text] [Related]
14. Exosomes transmit T790M mutation-induced resistance in EGFR-mutant NSCLC by activating PI3K/AKT signalling pathway.
Liu X; Jiang T; Li X; Zhao C; Li J; Zhou F; Zhang L; Zhao S; Jia Y; Shi J; Gao G; Li W; Zhao J; Chen X; Su C; Ren S; Zhou C
J Cell Mol Med; 2020 Jan; 24(2):1529-1540. PubMed ID: 31894895
[TBL] [Abstract][Full Text] [Related]
15. Exosomes-transmitted miR-7 reverses gefitinib resistance by targeting YAP in non-small-cell lung cancer.
Chen R; Qian Z; Xu X; Zhang C; Niu Y; Wang Z; Sun J; Zhang X; Yu Y
Pharmacol Res; 2021 Mar; 165():105442. PubMed ID: 33497805
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1.
Chen Z; Chen Q; Cheng Z; Gu J; Feng W; Lei T; Huang J; Pu J; Chen X; Wang Z
Cell Death Dis; 2020 Oct; 11(10):858. PubMed ID: 33056982
[TBL] [Abstract][Full Text] [Related]
17. Exosomal long non-coding RNA SOX2 overlapping transcript enhances the resistance to EGFR-TKIs in non-small cell lung cancer cell line H1975.
Zhou D; Xia Z; Xie M; Gao Y; Yu Q; He B
Hum Cell; 2021 Sep; 34(5):1478-1489. PubMed ID: 34244990
[TBL] [Abstract][Full Text] [Related]
18. let‑7 and miR‑17 promote self‑renewal and drive gefitinib resistance in non‑small cell lung cancer.
Yin J; Hu W; Pan L; Fu W; Dai L; Jiang Z; Zhang F; Zhao J
Oncol Rep; 2019 Aug; 42(2):495-508. PubMed ID: 31233201
[TBL] [Abstract][Full Text] [Related]
19. Cancer exosomal microRNAs from gefitinib-resistant lung cancer cells cause therapeutic resistance in gefitinib-sensitive cells.
Azuma Y; Yokobori T; Mogi A; Yajima T; Kosaka T; Iijima M; Shimizu K; Shirabe K; Kuwano H
Surg Today; 2020 Sep; 50(9):1099-1106. PubMed ID: 32052182
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA‑506‑3p reverses gefitinib resistance in non‑small cell lung cancer by targeting Yes‑associated protein 1.
Zhu J; Tao L; Jin L
Mol Med Rep; 2019 Feb; 19(2):1331-1339. PubMed ID: 30535506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
